SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010600
Filing Date
2024-03-20
Accepted
2024-03-20 07:04:24
Documents
14
Period of Report
2024-03-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39797
  Complete submission text file 0001493152-24-010600.txt   260800

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20240319.xsd EX-101.SCH 3944
3 XBRL DEFINITION FILE hrow-20240319_def.xml EX-101.DEF 26962
4 XBRL LABEL FILE hrow-20240319_lab.xml EX-101.LAB 37183
5 XBRL PRESENTATION FILE hrow-20240319_pre.xml EX-101.PRE 25582
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6565
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 24766249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)